Challenges associated with long-term therapies in CLL
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Clonal evolution – an important factor in treating CLL
Lenalidomide and ibrutinib: do they have a future in treating CLL?
Precision medicine, genomics and immunotherapies at ASH 2017